Clinical Trial Update: Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

Phase 1 trial results update evaluating dacomitinib in combination with radiotherapy, with or without cisplatin, for head and neck squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Dacomitinib (dacomitinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 1 | Status: COMPLETED